Medical Nutrition USA, Inc. Introduces New Fiber-Stat(R) Formulation With Prune Juice Concentrate
02 Octobre 2009 - 8:10PM
Marketwired
Medical Nutrition USA, Inc. (NASDAQ: MDNU) today announced the
introduction of a new Fiber-Stat® concentrated liquid fiber formula
that includes prune juice concentrate.
Recommended for chronic irregularity, low fiber intake, and to
support intestinal health, the new Fiber-Stat delivers a highly
effective "triple action" combination of three active ingredients
in a single, cost-effective and easy-to-take one-ounce dose.
"This unique combination of soluble fiber, prebiotic and prune
juice concentrate is rich in antioxidants, provides 60% of the
recommended daily value of fiber in each ounce, stimulates natural
bowel regulation and promotes colon health," said Frank A. Newman,
the Company's Chairman and Chief Executive Officer.
"Fiber-Stat was developed to address one of the most widespread
and demanding challenges to maintaining patient health and comfort
in long-term care and acute care institutions," Newman said. "New
Fiber-Stat demonstrates the value of our ongoing investment in
product development and our commitment to providing positive
clinical outcomes through evidence-based research."
The new Fiber-Stat formulation replaces an earlier version of
the product in Medical Nutrition USA's product line, which also
includes the Pro-Stat® line of targeted modular protein formulas
and UTI-Stat urinary tract cleansing complex.
According to the company, Fiber-Stat can be taken with any food
or beverage, does not interfere with drug or nutrient absorption
and can be administered via feeding tube. Fiber-Stat comes
ready-to-use with no mixing or dissolving required.
For more information, visit www.mnidirect.net.
About Medical Nutrition USA, Inc.
Medical Nutrition USA develops and distributes products for the
nutritionally at risk who are under medical supervision. Its
products are used primarily in long-term care facilities,
hospitals, dialysis clinics and bariatric clinics. The Company's
product lines include Pro-Stat®, Fiber-Stat® and UTI-Stat(TM), as
well as private label products. Additional information is available
at www.mdnu.com.
This news release contains forward-looking statements that are
subject to certain risks and uncertainties. Although we believe
that the expectations reflected in any of our forward-looking
statements are reasonable, actual results could differ materially
from those projected or assumed. Risks and uncertainties that could
cause or contribute to such material differences include, but are
not limited to, general economic conditions, changes in customer
demand, changes in trends in the nursing home, renal care, health
food and bariatric surgery markets, changes in competitive pricing
for products, and the impact of our competitors' new product
introductions. Our future financial condition and results of
operations, as well as any forward-looking statements are subject
to change and inherent risk and uncertainties. Other important
factors that may cause actual results to differ materially from
those expressed in forward-looking statements is contained in the
Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year
ended January 31, 2009 as filed with the Securities and Exchange
Commission on April 24, 2009 and Form 10-Q for the quarter ended
July 31, 2009 filed on September 11, 2009.
Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling Vice
President/CFO 800.221.0308 Email Contact Investor Relations Adam
Friedman 212.981.2529 x18 Email Contact
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024